Zylox-Tonbridge Medical Technology Co Ltd 2021 AR2

The report details the company's financial and operational performance for the fiscal year 2021, highlighting its successful initial public offering on the Hong Kong Stock Exchange. During the year, the company achieved significant commercialization progress, recording a revenue increase of 543.9% to RMB 177.9 million, driven by its neurovascular and peripheral-vascular interventional medical devices. The company also expanded its product portfolio with eight new NMPA approvals and two CE Marks, and successfully relocated to the new Zylox-Tonbridge Industry Park to scale up manufacturing capacity. Additionally, the report outlines the company's first comprehensive environmental, social, and governance disclosures, emphasizing its commitment to product quality, employee development, and green operations.

Company: Zylox-Tonbridge Medical Technology Co Ltd

Sector: Health Care

Country: China

Year: 2021

Type: AR2

Pages: 201

Back to company

Zylox-Tonbridge Medical Technology Co Ltd

Zylox-Tonbridge Medical Technology Co Ltd 2021 Annual Report

Annual Report

The report details the company's financial and operational performance for the fiscal year 2021, highlighting its successful initial public offering on the Hong Kong Stock Exchange. During the year, the company achieved significant commercialization progress, recording a revenue increase of 543.9% to RMB 177.9 million, driven by its neurovascular and peripheral-vascular interventional medical devices. The company also expanded its product portfolio with eight new NMPA approvals and two CE Marks, and successfully relocated to the new Zylox-Tonbridge Industry Park to scale up manufacturing capacity. Additionally, the report outlines the company's first comprehensive environmental, social, and governance disclosures, emphasizing its commitment to product quality, employee development, and green operations.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2021

Reporting Period

Jan 1, 2021 - Dec 31, 2021

Fiscal Year

2021

Type

Annual Report with Sustainability Disclosures

Language

English

Pages

 

File Size

 

Standards & Assurance

Materiality Assessment

Assurance

Assurance Provider

Assurance Standard

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Water Consumption

Workplace Fatalities

Employees